Business Wire

Security Luminary René Bonvanie, of Palo Alto Networks, Joins Board of Belgian Security Company Guardsquare; Felix van de Maele Appointed Board Advisor

Del

Guardsquare, a market-leading security company specializing in protecting the next generation of complex mobile applications, has appointed René Bonvanie, the CMO of Palo Alto Networks, to its board of directors. Felix Van de Maele, the CEO and co-founder of Belgian data company Collibra—a “unicorn” valued at US$1 billion—is joining as a board advisor.

Guardsquare—a company at the forefront of helping enterprises manage the digital transformation of their businesses—makes a widely used open-source security platform already in use with over a million apps to enable agile software innovation. Specifically, the company’s technology protects increasingly critical mobile apps, usually being deployed outside corporate firewalls, from dangerous security threats. Guardsquare is pioneering mobile and IoT application security in a world where over 20 billion connected devices are expected to be running applications at the edge by 2020. Earlier this year, Guardsquare announced a $29 million investment from Battery Ventures. As part of the transaction, Battery General Partner Dharmesh Thakker and Battery Principal Paul Morrissey joined Guardsquare’s board of directors.

The board now welcomes René Bonvanie as a new member. Bonvanie has more than thirty years of executive management and marketing experience in enterprise technology and has led marketing at Palo Alto Networks since 2009. Bonvanie also serves on the board of IoT security company Armis and, prior to his current role at Palo Alto Networks, had executive marketing roles at Business Objects, VERITAS, and Oracle.

Bonvanie stated: “The cybersecurity landscape is evolving rapidly because of the increasing adoption of connected devices and the advent of new technologies such as 5G. Guardsquare provides security capabilities that are increasingly critical in this changing landscape. I look forward to using my European background and security expertise to drive the adoption of Guardsquare’s products on both sides of the Atlantic.”

Felix Van de Maele will join as a board advisor. Van de Maele is the CEO and co-founder of Belgian unicorn Collibra, a leader in enterprise data governance and catalog software. He brings to the table an impressive track-record in scaling a high-tech European enterprise and gaining a strong foothold in the US market.

“Using the experience I gained with Collibra, I am looking forward to providing strategic advice to Guardsquare’s board—and am excited to help another Belgian tech company to expand in the US,” Van de Maele said.

“Bonvanie and Van de Maele both have in-depth knowledge of the software industry and its needs,” said Roel Caers, CEO of Guardsquare. “They believe that our company’s mobile security solutions are important for any organization operating in this mobile-first world. Both men will join forces with Belgian fintech pioneer and Guardsquare board member Jurgen Ingels to accelerate Guardsquare’s growth.”

About Guardsquare

Guardsquare is the global reference in mobile application protection. It was founded in 2014 by Heidi Rakels, Guardsquare’s current president, and Eric Lafortune, now CTO of the company. Guardsquare develops premium software for the protection of mobile applications against reverse engineering and hacking. Their products are used across the world in a broad range of industries, from financial services, e-commerce and the public sector to telecommunication, gaming and media. Guardsquare is based in Leuven (Belgium) and San Francisco. Read more on www.guardsquare.com.

Contact information

Steven Surdiacourt
steven.surdiacourt@guardsquare.com
+32 (0)16 920 646

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards17.5.2019 12:00:00 CESTPressemelding

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, was named the Best-In-Class Cloud Service Provider by the UK Cloud Awards 2019 at a ceremony here last night. Now in its sixth year, the UK Cloud Awards recognise innovation and excellence in the cloud industry by showcasing leading companies, customers and individuals in the United Kingdom. Workiva was recognised for its Wdesk platform that helps organisations consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders. Workiva, the global leader in XBRL and Inline XBRL, is also streamlining how customers comply with the European Securities and Markets Authority's mandate for Inline XBRL for European Single Electronic Format (ESEF) reporting. More than 5,000 EU issuers will be required to use ESEF taxonomy for their annual financial reports, ending on or after Jan

Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 201917.5.2019 10:13:00 CESTPressemelding

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, today announced a poster presentation highlighting the top-line results from a Phase 2a (Proof of Concept) study of NRD.E1 for the treatment of diabetic neuropathic pain (DNP). The poster presentation took place at the 7th International Congress on Neuropathic Pain Meeting (NeuPSIG) in London, UK on May 9-11, 2019. “This was our first communication at a leading neuropathic pain-focused event. Novaremed’s lead drug, NRD.E1 is a non-opioid small molecule for the treatment of neuropathic pain. The results of our Phase 2a in patients with DNP showed clinically relevant treatment benefit from NRD.E1 across multiple primary and secondary endpoints, providing a strong scientific foundation for advancing the development of NRD.E1 into the upcoming global Phase 2b study in DNP,” said Sara Mangialaio, Head of R&D and Chief Medical Officer of Novaremed AG. “NRD.E1 has the potential to address a major unmet medical need in DNP.” Poste

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology17.5.2019 09:38:00 CESTPressemelding

The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global Deployment of Precision Oncology. The current status of Precision Oncology across the globe will be examined with the exceptional participation of the chairmen of the event, Richard L. Schilsky, Chairman WIN Consortium(*), Senior Vice-President and Chief Medical Officer of ASCO, and Josep Tabernero, Vice Chairman WIN Consortium, President of ESMO and Director of Vall d’Hebron Institute of Oncology, Spain. Global experience will be shared: Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials at UT MD Anderson Cancer Center, USA Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations, UT MD Anderson Cancer Center, USA The Value of Personalized Medici

Corsearch Acquires Principium Trademark Watch and Domain Services Businesses17.5.2019 08:00:00 CESTPressemelding

Corsearch, the global brand creation, clearance, and protection leader, is pleased to announce the acquisition of the Principium Strategies trademark watch and domain services businesses, the brand protection subsidiary of Ladas and Parry LLP, a leader in global intellectual property law. The acquisition is effective immediately, solidifying and expanding Corsearch’s full-service trademark solutions offering for clients and brands globally. Principium is Corsearch’s third acquisition since becoming a standalone company in January 2018. The acquisition brings Corsearch’s employee count to more than 350 operating in 28 locations worldwide and adds valuable industry expertise and additional capabilities to Corsearch. “This is another really exciting acquisition for our business and a step forward in the evolution of Corsearch,” said Stephen Stolfi, Chief Commercial Officer of Corsearch. “Principium has provided clients with industry-leading trademark watching services for over 80 years an

CNT Among SAP’s "Best of the Best"17.5.2019 08:00:00 CESTPressemelding

Since 2005, SAP is honoring the best of the best SAP projects yearly in Europe, Middle East and Africa. In 2018, 280 customers from 15 markets submitted their regional Gold Award-winning projects. CNT Management Consulting from Vienna won Bronze twice – together with its customers HOERBIGER and TANNPAPIER – a happy day for CNT’s CEO Andreas Doerner. "We are now on the podium for the second time with two projects – thanks to the trust of our customers." The SAP Quality Awards EMEA were presented at an exceptionally festive ceremony in Heidelberg Castle (Baden-Wuerttemberg), and only twelve SAP customers were able to take home the most wanted trophies that were presented by SAP Presidents Brian Duffy (EMEA North) and Hartmut Thomsen (Middle and Eastern Europe). The jury evaluated the projects according to the ten SAP quality principles and the question of whether the respective project could fulfill the expectations of its clients. HOERBIGER - Category Business Transformation Headquarter

EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe17.5.2019 07:25:00 CESTPressemelding

EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH. “This acquisition represents another milestone in the expansion of EVER Pharma’s commercial footprint in Europe. With this new operation, EVER Pharma extends its portfolio in Germany and establishes a solid platform for the growth of its portfolio and pipeline” commented Georges Kahwati, General Manager of EVER Pharma. “We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner. About EVER Pharma: EVER